Short Summary
Janssen Pharmaceutica N.V. filed an appeal challenging the rejection of its Indian Patent Application no. 4805/DELNP/2007 by the Controller of Patents and Anr. The application was rejected on grounds of lacking inventive step (Section 2(1)(j)) and insufficient disclosure (Section 10) of the Patents Act, 1970.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Janssen Pharmaceutica N.V. vs The Controller Of Patents And Anr is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
M/s.Vaibhav FoodsvsNarendra Kumar Mali / M/s.FOOD INDIA
M/s. Vaibhav Foods filed a suit against Narendra Kumar Mali and M/s. FOOD INDIA alleging infringement and passing off related to their unique chocolate packaging design. The Plaintiff demonstrated that they had successfully registered two designs (Nos. 274667 and 274668) for the specific arrangement and color combination of chocolates. The court found that the defendants were manufacturing and selling chocolates using a similar and identical design, leading to confusion in the market.
Ajp Impex Private LimitedvsThe Registrar Of Trademark Delhi & Anr.
The Delhi High Court granted an interim stay in favor of Ajp Impex Private Limited regarding a trademark dispute. Despite the respondent failing to appear or file a reply, the court upheld and made absolute the existing interim order from February 2025. This decision allows the petitioner to maintain protection against the impugned mark until the final resolution of the main petition.
Gruner AgvsGuangxi Ramway Technology Co. Ltd.
The plaintiff filed a suit seeking permanent injunctions and damages against the defendants for alleged patent infringement. The court registered the plaint as a suit, issued summons, and set timelines for filing written statements and replication. Various interim applications regarding stay, additional documents, and directions to Customs were also addressed.
Novo Nordisk A/S & AnrvsDr. Reddy's Laboratories Limited
Novo Nordisk filed a commercial suit seeking an interim injunction against Dr. Reddy's Laboratories concerning their patented composition involving semaglutide. The court heard arguments, noted affidavits from both sides, and allowed procedural applications while directing the parties to proceed with pleadings.
Ms C R Auluck And Sons Private LimitedvsMs Dharamlaxmi Machines Private Limited & Anr.
The Delhi High Court granted a stay on the registered trademark 'DHARMLAXMI' belonging to the respondent, in favor of the petitioner who owns 'LUXMI'. The court found prima facie evidence suggesting deceptive similarity between the two marks and products (sewing machines), noting that the respondent was using the mark in a manner different from its registration. This interim order is crucial for the petitioner as it prevents the respondent from continuing to operate under the disputed trademark while the rectification petition proceeds.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.